Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff

20234 citationsJournal Articlegold Open Access

Authors

Shannon Gwin Mitchell · Friends Research Institute

Julia Jester

Jan Gryczynski · Friends Research Institute

Melanie Whitter · National Association of State Alcohol and Drug Abuse Directors

Douglas B. Fuller · National Association of State Alcohol and Drug Abuse Directors

Caroline Halsted · National Association of State Alcohol and Drug Abuse Directors

Robert P. Schwartz ·

Abstract

The experienced reflections of SOTAs and OTP providers on methadone practice changes during the COVID-19 pandemic offer insights on SAMHSA's proposed revisions to its OTP regulations. Trial registration Clinicaltrials.gov # NCT04188977.

Topics & Keywords

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Cannabis and Cannabinoid Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Addiction Science & Clinical Practice

Volume 18, Issue 1, pp. 61-61

DOI: 10.1186/s13722-023-00417-7

Field-Weighted Citation Impact: 1.17

Command Palette